Patent application number | Description | Published |
20150015210 | VOLTAGE-ENHANCED ENERGY STORAGE DEVICES - The present disclosure provides an energy storage device comprising at least one electrochemical cell comprising a negative current collector, a negative electrode in electrical communication with the negative current collector, an electrolyte in electrical communication with the negative electrode, a positive electrode in electrical communication with the electrolyte and a positive current collector in electrical communication with the positive electrode. The negative electrode comprises an alkali metal. Upon discharge, the electrolyte provides charged species of the alkali metal. The positive electrode can include a Group IIIA, IVA, VA and VIA of the periodic table of the elements, or a transition metal (e.g., Group 12 element). | 01-15-2015 |
20150132627 | VOLTAGE-ENHANCED ENERGY STORAGE DEVICES - The present disclosure provides an energy storage device comprising at least one electrochemical cell comprising a negative current collector, a negative electrode in electrical communication with the negative current collector, an electrolyte in electrical communication with the negative electrode, a positive electrode in electrical communication with the electrolyte and a positive current collector in electrical communication with the positive electrode. The negative electrode comprises an alkali metal. Upon discharge, the electrolyte provides charged species of the alkali metal. The positive electrode can include a Group IIIA, IVA, VA and VIA of the periodic table of the elements, or a transition metal (e.g., Group 12 element). | 05-14-2015 |
Patent application number | Description | Published |
20090013175 | METHOD AND APPARATUS FOR CONTROLLING THE FLOW OF DATA ACROSS A NETWORK INTERFACE - The present invention performs “flow control” based on the remaining encryption capacity of an encrypted outbound network interface link of a network routing device, such as a router or switch. As the encrypted link begins to run low on encryption key material, this invention begins to discard datagrams queued for transit across that link, in order to signal distant host computers that they should slow down the rate at which they are sending datagrams. The invention, which is particularly useful in cryptographically protected networks that run the TCP/IP protocol stack, allows fine-grained flow control of individual traffic classes because it can determine, for example, how various classes of data traffic (e.g., voice, video, TCP) should be ordered and transmitted through a network. Thus, the invention can be used to implement sophisticated flow control rules so as to give preferential treatment to certain people, departments or computers. | 01-08-2009 |
20100020824 | PACKET HEADER COMPRESSION FOR LOSSY CHANNELS - The disclosed systems and methods provide for the compression and decompression of packet headers. An uncompressed header can be compressed in size to form a smaller, compressed header, such that the compressed header can include values that can be used to re-produce the uncompressed header. A compressed header can include at least two such values. A first value of the at least two values can be computed based on a second, earlier uncompressed header and can be used to derive the uncompressed header. Similarly, a second value of the at least two values can be computed based on a third uncompressed header and can be used to derive the same uncompressed header. Accordingly, the uncompressed header can be derived based on the first value and the second uncompressed header, or based on the second value and the third uncompressed header. The uncompressed header, second uncompressed header, and third uncompressed header can be associated with different packets. | 01-28-2010 |
20100027556 | HYBRID COMMUNICATIONS LINK - A hybrid communications link includes a slow, reliable communications link and a fast unreliable communications link. Communication via the hybrid communications link selectively uses both the slow, reliable communications link and the fast, unreliable communications link. | 02-04-2010 |
20100046484 | TIME DIVISION MULTIPLE ACCESS FOR NETWORK NODES WITH MULTIPLE RECEIVERS - A system facilitates communication among nodes in a wireless network. A timeslot is assigned to each of a group of nodes ( | 02-25-2010 |
20100046555 | METHOD AND APPARATUS FOR INFORMATION DISSEMINATION - A system and method for transmitting information to a group of recipient devices [ | 02-25-2010 |
20100214974 | HYBRID COMMUNICATIONS LINK - A hybrid communications link includes a slow, reliable communications link and a fast unreliable communications link. Communication via the hybrid communications link selectively uses both the slow, reliable communications link and the fast, unreliable communications link. | 08-26-2010 |
20110271012 | PACKET HEADER COMPRESSION FOR LOSSY CHANNELS - The disclosed systems and methods provide for the compression and decompression of packet headers. An uncompressed header can be compressed in size to form a smaller, compressed header, such that the compressed header can include values that can be used to re-produce the uncompressed header. A compressed header can include at least two such values. A first value of the at least two values can be computed based on a second, earlier uncompressed header and can be used to derive the uncompressed header. Similarly, a second value of the at least two values can be computed based on a third uncompressed header and can be used to derive the same uncompressed header. Accordingly, the uncompressed header can be derived based on the first value and the second uncompressed header, or based on the second value and the third uncompressed header. The uncompressed header, second uncompressed header, and third uncompressed header can be associated with different packets. | 11-03-2011 |
20150029914 | ENERGY EFFICIENT FORWARDING IN AD-HOC WIRELESS NETWORKS - A system for conserving energy in a multi-node network ( | 01-29-2015 |
20150063325 | RECEIVER SCHEDULING IN WIRELESS NETWORKS - A wireless apparatus utilizes a wireless transceiver, in communication with a processor, to transmit and receive messages via a wireless network. The wireless transceiver may receive a schedule definition for devices affiliated with a node of the wireless network. The processor may determine, from the received schedule definition, one or more time periods allocated to the wireless apparatus. The wireless transceiver may communicate with the wireless network in accordance with at least one of the one or more time periods. | 03-05-2015 |
Patent application number | Description | Published |
20080221554 | Deploying Embolic Coils - An embolic coil delivery system includes a catheter and an embolic coil disposed within the catheter, the embolic coil including a coil wire and a fiber bundle. A method of producing an embolic coil delivery system includes: advancing a delivery sheath over a distal end of an embolic coil while applying tension to the embolic coil via a retaining device that is attached to the distal end of the embolic coil. | 09-11-2008 |
20080221654 | SYSTEMS AND METHODS FOR DELIVERING A DETACHABLE IMPLANTABLE DEVICE - Disclosed herein are various systems and methods for delivering implantable devices, such as, for example detachable embolic coils. The systems can include an embolic coil mated to a pusher wire via a detachable link comprising first and second engaging members and an expandable member or a sleeve. The expandable member or sleeve can reduce relative movement between the engaging members to inhibit premature detachment and/or jamming of the detachable link as the embolic coil is delivered through a catheter. | 09-11-2008 |
20080234723 | MICROCATHETER INTRODUCER SHEATH - The present invention includes an introducer sheath. The sheath may comprise a first proximal elongated section having a first outer diameter and a first inner diameter, and a main body elongated section having a second inner diameter and a second outer diameter, wherein the second outer diameter is larger than the first outer diameter. The sheath may further include a distal section having an outer wall that tapers from the second outer diameter of the main body elongated section to a smaller distal outer diameter. | 09-25-2008 |
20110125147 | SYSTEMS AND METHODS FOR ABLATION OF TISSUE - A system for treating tissue includes a probe assembly having a cannula, a shaft, and one or more needle electrodes. The shaft has a distal end, a proximal end, and a lumen extending between the distal and proximal ends of the shaft, and is slidable within the lumen of the cannula. Each needle electrode has a lumen that may be placed in communication with a port at a proximal end of the probe assembly, and is configured to deliver an occlusive element to a site. The system may further include an embolization actuator for delivering the occlusive element. A method of treating tissue includes placing an electrode at a site of a treatment region, occluding at least a part of a vessel located adjacent the site by delivering an occlusion element from an electrode, and delivering ablation energy to the site while the vessel is at least partially occluded. | 05-26-2011 |
20130165870 | MICROCATHETER INTRODUCER SHEATH - The present invention includes an introducer sheath. The sheath may comprise a first proximal elongated section having a first outer diameter and a first inner diameter, and a main body elongated section having a second inner diameter and a second outer diameter, wherein the second outer diameter is larger than the first outer diameter. The sheath may further include a distal section having an outer wall that tapers from the second outer diameter of the main body elongated section to a smaller distal outer diameter. | 06-27-2013 |
20130238012 | EMBOLIC COILS - Embolic coils, as well as related methods, devices, and compositions, are disclosed. | 09-12-2013 |
20140081313 | EMBOLIC COILS AND RELATED COMPONENTS, SYSTEMS, AND METHODS - Embolic coils, and related components, systems, and methods, are disclosed. | 03-20-2014 |
Patent application number | Description | Published |
20080217252 | Bacteria Deactivation Method And Apparatus - A bacteria deactivation device that has a porous medium through which water and bacteria contained in the water, like | 09-11-2008 |
20080296258 | Plenum reactor system - Techniques for generating reactions on surfaces that can operate at room temperature and pressure with visible laser light as a radiation source and environmentally sound gases for processing. The apparatus is highly compact, simple, reliable and low cost to operate and maintain, and can dry clean and condition surfaces without causing damage or leaving a residue. Gas is injected at one end of a plenum, directed through the plenum in the presence of the laser radiation, and exhausted at the other end. The plenum creates a highly confined space for directional laminar movement of gas, laser light and by-products, permitting a high degree of uniformity and reaction efficiency. Minimal internal surface area and volume of the reactor prevents by-products from forming, eliminating costly cleaning and downtime. | 12-04-2008 |
20080299780 | Method and apparatus for laser oxidation and reduction - A method and apparatus using electromagnetic radiation and gas to create oxidation and reduction reactions on a device, such as a semiconductor wafer surface. In one embodiment, a scanned laser and gas may be employed in a number of oxidation and/or reduction reactions in a single system without using multiple pieces of equipment, corrosive chemicals and gases, high temperature and pressure chamber environments, waste treatment processes, and/or extra process steps typically required in existing processes. | 12-04-2008 |
20090323739 | LASER OPTICAL SYSTEM - A compact optical system is provided for delivering laser radiation with high optical efficiency and uniformity. The optical system includes, in order of the propagation of light, an expander for producing a collimated beam, a beam shaper including a flat window with a diffraction pattern on one side for transforming the collimated beam into a square top-hat output beam, a corrector for bending the square top-hat output beam back to a system axis, a scan head to scan the square top-hat output beam across the substrate, and a scan lens to image the beam at the substrate plane. | 12-31-2009 |
Patent application number | Description | Published |
20110061679 | Photoreactive Removal of Ion Implanted Resist - A method for removing ion implanted photoresist from a surface of a substrate is provided. The method may include introducing a gas to a reaction chamber containing the substrate; illuminating the ion implanted photoresist with radiation from a laser in the presence of the gas; and scanning the radiation across the surface in the presence of the gas to photoreactively remove the ion implanted photoresist from the surface. | 03-17-2011 |
20110139757 | METHOD AND APPARATUS FOR PROCESSING SUBSTRATE EDGES - A method and apparatus for processing substrate edges is disclosed that overcomes the limitations of conventional edge processing methods and systems used in semiconductor manufacturing. The edge processing method and apparatus of this invention includes a laser and optical system to direct a beam of radiation onto a rotating substrate supported by a chuck. The optical system accurately and precisely directs the beam to remove or transform organic or inorganic films, film stacks, residues, or particles, in atmosphere, from the top edge, top bevel, apex, bottom bevel, and bottom edge of the substrate in a single process step. An optional gas injector system directs gas onto the substrate edge to aid in the reaction. Reaction by-products are removed by means of an exhaust tube enveloping the reaction site. This invention permits precise control of an edge exclusion width, resulting in an increase in the number of usable die on a wafer. Wafer edge processing with this invention replaces existing methods that use large volumes of purified water and hazardous chemicals including solvents, acids, alkalis, and proprietary strippers. | 06-16-2011 |
20110139759 | FIBER-OPTIC BEAM DELIVERY SYSTEM FOR WAFER EDGE PROCESSING - A method and apparatus for processing substrate edges is disclosed that overcomes the limitations of conventional edge processing methods and systems used in semiconductor manufacturing. The edge processing method and apparatus of this invention includes a laser and fiber-optic system to direct laser radiation onto a rotating substrate supported by a chuck. A laser beam is transmitted into a bundle of optical fibers, and the fibers accurately and precisely direct the beam to remove or transform organic or inorganic films, film stacks, residues, or particles, in atmosphere, from the top edge, top bevel, apex, bottom bevel, and bottom edge of the substrate in a single process step. Reaction by-products are removed by means of an exhaust tube enveloping the reaction site. This invention permits precise control of an edge exclusion width, resulting in an increase in the number of usable die on a wafer. Wafer edge processing with this invention replaces existing methods that use large volumes of purified water and hazardous chemicals including solvents, acids, alkalis, and proprietary strippers. | 06-16-2011 |
20110147350 | MODULAR APPARATUS FOR WAFER EDGE PROCESSING - A modular wafer edge processing apparatus is disclosed that overcomes the limitations of conventional edge processing methods and systems used in semiconductor manufacturing. The modular apparatus can be integrated into wafer tracks, cluster tools, and other volume manufacturing systems. The edge processing apparatus of this invention includes a laser that can either be contained inside the module, or mounted externally to feed multiple modules and thereby reduce system cost. The apparatus contains a beam delivery subsystem to direct a beam of radiation onto the edges of a rotating substrate supported by a chuck. The optical system accurately and precisely directs the beam to remove or transform organic or inorganic films, film stacks, residues, or particles, in atmosphere, from the top edge, top bevel, apex, bottom bevel, and bottom edge of the substrate in a single process step. Reaction by-products are removed by means of an exhaust tube enveloping the reaction site. This invention permits precise control of an edge exclusion width, resulting in an increase in the number of usable die on a wafer. Wafer edge processing with this invention replaces existing methods that use large volumes of purified water and hazardous chemicals including solvents, acids, alkalis, and proprietary strippers. | 06-23-2011 |
20110168672 | METHOD AND APPARATUS FOR PROCESSING SUBSTRATE EDGES - A method and apparatus for processing substrate edges is disclosed that overcomes the limitations of conventional edge processing methods and systems used in semiconductor manufacturing. The edge processing method and apparatus of this invention includes a laser and optical system to direct a beam of radiation onto a rotating substrate supported by a chuck, in atmosphere. The optical system accurately and precisely directs the beam to remove or transform organic or inorganic films, film stacks, residues, or particles from the top edge, top bevel, apex, bottom bevel, and bottom edge of the substrate. An optional gas injector system directs gas onto the substrate edge to aid in the reaction. Process by-products are removed via an exhaust tube enveloping the reaction site. This invention permits precise control of an edge exclusion zone, resulting in an increase in the number of usable die on a wafer. Wafer edge processing with this invention replaces existing solvent and/or abrasive methods and thus will improve die yield. | 07-14-2011 |
20110185971 | Laser doping - The disclosed apparatus and method provides substrate impurity doping wherein a laser rapidly scans a substrate while simultaneously a uniform laminar flow of reactive gas is injected, the interaction of the laser radiation and the dopant results in a uniform diffusion of the dopant species in all planes (X,Y,Z) of the substrate. Laser energy density, wavelength, and pulse geometry are adjustable, in a simple system for volume manufacturing, to provide depth and dose control of the dopant. The system optics can be focused to form a high resolution laser beam to directly write the doping area pattern geometry. Alternatively the laser beam can be optically expanded to form a large diameter beam for large area diffusion of the dopant through a patterned mask. | 08-04-2011 |
20120187052 | BACTERIA DEACTIVATION METHOD AND APPARATUS - A bacteria deactivation device that has a porous medium through which water and bacteria contained in the water, like | 07-26-2012 |
20140158640 | PORTABLE PATHOGEN DEACTIVATION METHOD AND APPARATUS - A portable, non-filtering, microorganism deactivation device for treating water contaminated with harmful bacteria such as | 06-12-2014 |
Patent application number | Description | Published |
20080269228 | HYDRAZIDE-CONTAINING HEPATITIS C SERINE PROTEASE INHIBITORS - The present invention relates to novel hydrazide-containing compounds of Formula I or Formula II, including pharmaceutically acceptable salts, esters, or prodrugs thereof which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. | 10-30-2008 |
20090036678 | Process for the synthesis of E1 activating enzyme inhibitors - The present invention provides processes and synthetic intermediates for the synthesis of 4-substituted ((1S,2S,4R)-2-hydroxy-4-{7H-pyrrolo[2,3-d]pyrimidin-7-yl}cyclopentyl)methyl sulfamates, which are E1 activating enzyme inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with E1 activity. | 02-05-2009 |
20090325903 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF - The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. | 12-31-2009 |
20130165390 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF - The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. | 06-27-2013 |
20140018301 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF - The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. | 01-16-2014 |
20140343314 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF - The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. | 11-20-2014 |
20140349966 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF - The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. | 11-27-2014 |
20150080573 | PROCESS FOR THE SYNTHESIS OF E1 ACTIVATING ENZYME INHIBITORS - The present invention provides processes and synthetic intermediates for the synthesis of 4-substituted ((1S,2S,4R)-2-hydroxy-4-{7H-pyrrolo[2,3-d]pyrimidin-7-yl}cyclopentyl)methyl sulfamates, which are E1 activating enzyme inhibitors, and are useful for the treatment of disorders of cell proliferation, particularly cancer, and other disorders associated with E1 activity. | 03-19-2015 |
Patent application number | Description | Published |
20110053938 | Compounds and Compositions For Treating Cancer - The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed. | 03-03-2011 |
20120059004 | Compounds And Compositions For Treating Cancer - The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed. | 03-08-2012 |
20120157455 | Compounds And Compositions For Treating Cancer - The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed. | 06-21-2012 |
20130203757 | Compounds And Compositions For Treating Cancer - The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed. | 08-08-2013 |
20130237539 | Compounds and Compositions for Treating Cancer - The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed. | 09-12-2013 |
Patent application number | Description | Published |
20080249103 | Sirtuin polymorphisms and methods of use thereof - Provided herein are methods for diagnosis and prognosis using polymorphic variants of sirtuins. Such polymorphic may be used, for example, to identify subjects that would be responsive to treatment with a sirtuin modulating compound and/or subjects that are suffering from or susceptible to a disease mediated by a sirtuin. Also provided are methods for determining the predictive value of a sirtuin polymorphic variant, methods for evaluating sirtuin modulating compounds, and methods for determining appropriate dosage and/or treatment regimens for subjects having one or more sirtuin polymorphic variants. Screening methods for identifying sirtuin modulating compounds using polymorphic variants of a sirtuin are also provided. | 10-09-2008 |
20110009496 | RESVERATROL FORMULATIONS - Resveratrol can be used to treat or inhibit the onset of many diseases that are related to the aging process, but large doses are required. The present invention provides concentrated liquid formulations of resveratrol, typically having a resveratrol concentration of at least 10% by weight. These formulations improve patient compliance because the patient need not consume such a large volume of a resveratrol formulation. | 01-13-2011 |
20140336248 | THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE - Aqueous compositions comprising salinomycin, or a pharmaceutically acceptable salt thereof, miscible organic solvents, and solubilizers and/or emulsifying agents are disclosed. The formulations disclosed herein are useful in the treatment of cancer, especially cancers associated with cancer stem cells or cancerous mesenchymal cells. The method of treating a subject may further comprise identifying a subject having a disorder suitable for treatment with the aqueous compositions described, comprising detecting one or more biomarkers predictive of the prevalence of a cancer having or enriched for cancer stem cells (CSCs). | 11-13-2014 |